Skip to main content

Table 1 Clinical characteristics of patients

From: Quality of life during chemotherapy, hormonotherapy or antiHER2 therapy of patients with advanced, metastatic breast cancer in clinical practice

CharacteristicNumber
Performance status
 0168 (48%)
 1168 (48%)
 215 (4%)
Primary location
 right breast168 (48%)
 left breast183 (52%)
Age (years)
 31–4026 (7%)
 41–5063 (18%)
 51–6070 (20%)
 61–7091 (26%)
 71–8091 (26%)
 81–9010 (3%)
Family history of neoplastic disease
 yes53 (15%)
 no298 (85%)
Place of residence
 city232 (66%)
 rural area119 (34%)
Smoking status
 yes133 (38%)
 no218 (62%)
Education
 lower than secondary88 (25%)
 secondary186 (53%)
 higher77 (22%)
Disease dissemination
 primary147 (42%)
 secondary204 (58%)
Chemotherapy regimen
 chemotherapy139 (40%)
 hormone therapy121 (34%)
 anti-HER2 therapy91 (26%)